Health Results-Based Financing Impact Evaluation 2012, Health Facility Baseline Survey
Central African Republic, 2012
Get Microdata
Reference ID
CAF_2012_RBFIE-FBL_v01_M
Producer(s)
Damien de Walque
Collection(s)
Metadata
Created on
Oct 17, 2014
Last modified
Jun 16, 2015
Page views
139690
Downloads
65239
- Data files
-
F1_Aire de
Santé (section
15) -
F1_Disponibilité
des medicaments -
F1_Evaluation
des FOSA -
F1_Liste des
personnel(section
4) -
F1_Ressource
humaine -
F1_Utilisation
de SNIS(section
8) -
F2_Agents de
santé -
F3_Oservation
Directe CPN -
F4_Observation
Directe Moins
de 5ans -
F5_Sortie de
CPN -
F6_Sortie de
moins de 5ans -
F7_Sortie Plus
de 5ans
Type de médicament administrer 5 (f7_02_19_5)
Data file: F7_Sortie Plus de 5ans
Overview
Valid:
30
Invalid:
0
Type:
Discrete
Start:
299
End:
320
Width:
22
Range:
-
Format:
character
Questions and instructions
Literal question
Quel médicament vous a-t-on donné?
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ASPIRINE | 1 |
3.3%
|
|
| Albindazole 400g | 2 |
6.7%
|
|
| Alyst | 1 |
3.3%
|
|
| CTN 480 MG 15 CP | 1 |
3.3%
|
|
| Cipro+quinine | 1 |
3.3%
|
|
| DAKIN | 1 |
3.3%
|
|
| DEXA 1AMP | 1 |
3.3%
|
|
| Denamethen 2Amp | 1 |
3.3%
|
|
| Dypirone,sparadrap,sér | 1 |
3.3%
|
|
| Gant-Lame | 1 |
3.3%
|
|
| IBUPROFEN . LASYLIN .A | 1 |
3.3%
|
|
| METRONIDAZOL | 1 |
3.3%
|
|
| PARACETAMOLE | 1 |
3.3%
|
|
| Qx | 1 |
3.3%
|
|
| SERINGUE | 1 |
3.3%
|
|
| SERINGUE,VITAMINE,COAR | 1 |
3.3%
|
|
| SPARADRAP | 1 |
3.3%
|
|
| SUCUS 5ML | 1 |
3.3%
|
|
| SUU 5cc 1 | 1 |
3.3%
|
|
| Sulfedo | 1 |
3.3%
|
|
| V.B COMPLEXE | 1 |
3.3%
|
|
| catether perfuseur | 1 |
3.3%
|
|
| dipyrone | 1 |
3.3%
|
|
| genta | 1 |
3.3%
|
|
| paracetamol | 1 |
3.3%
|
|
| seringue | 1 |
3.3%
|
|
| sparadra | 1 |
3.3%
|
|
| vitamine B12 | 2 |
6.7%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question post text
Enquêteur: vérifiez les médicaments pour confirmation